Di(2-ethylhexyl)phthalate
(DEHP) is widely used as a plasticizer
to improve product flexibility and workability. Lycopene (LYC) is
a natural compound and has promising preventive potentials, especially
antireproductive toxicity, but the specific underlying mechanism is
yet to be fully defined. Our study investigated the effect of LYC
on DEHP-induced spermatogenesis disorders. Male ICR mice were treated
with DEHP (500 or 1000 mg/kg BW/day) and/or LYC (5 mg/kg BW/day) for
28 days. Our results indicated that LYC could relieve the DEHP-induced
injury of seminiferous tubules and spermatogenic cells, swelling of
endoplasmic reticulum (ER), and an increase of mitochondria. LYC prevented
increased levels of nuclear damage to DNA and the deformity rate and
decreased values of sperm motility, number, and density. Moreover,
LYC treatment decreased DEHP-induced nuclear accumulation of aryl
hydrocarbon receptor (AHR) and AHR nuclear translocator (ARNT), and
the expressions of their downstream target genes such as cytochrome
P450-dependent monooxygenases (CYP) 1A1, 1A2, and 1B1 were markedly
reduced to normal in the LYC treatment group. Our study showed that
LYC can prevent DEHP-induced spermatogenic disorders via an AHR/ARNT
signaling system. This study provided new evidence of AHR as a target
for LYC, which can prevent DEHP-induced toxicity.